Alembic Pharma gets USFDA nod for thyroid disorder and cancer treatment drug
Alembic Pharmaceuticals Ltd. on Friday, May 22, said it has received the final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Levothyroxine Sodium Tablets USP across multiple dosage strengths. The approved product is therapeutically equivalent to AbbVie Inc.’s Synthroid Tablets and is available in strengths ranging…
